Moleculin Selected to Present at the 2nd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care

/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...

Related Keywords

Houston ,Texas ,United States ,Poland ,Robert Shepard ,Jenene Thomas ,Walter Klemp ,Roswell Park Comprehensive Cancer Center ,Moleculin Biotech Inc ,Linkedin ,Twitter ,Nasdaq ,Exchange Commission ,Opportunities For International Collaborations Funding ,Marie Sklodowska Curie Symposium On Cancer Research ,Preclinical Research Into Clinical Trials ,Securities Exchange ,Facebook ,Prnewswire Moleculin Biotech Inc ,Translational Research ,Clinical Development ,Annual Marie Sklodowska Curie Symposium ,Cancer Research ,Chief Executive ,International Collaborations ,Translating Preclinical Research Into Clinical ,Moleculin Biotech ,Transcription Modulator ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Nc ,